Back to
Orbis Allan Gray Ltd
CRSP7 quarters
Position history for
Orbis Allan Gray Ltd's holdings in CRISPR THERAPEUTICS AG
Yes. Orbis Allan Gray holds 5,449,161 shares of CRSP (Crispr Therapeutics), worth $297.2M, as of its Q2 2026 13F filing. It reduced the position by 656,850 shares (-10.8%) from Q1 2026. Orbis Allan Gray has held CRSP since Q4 2024, across 7 quarterly 13F filings. CRSP is 1.0% of Orbis Allan Gray's reported 13F portfolio.
Current Value
$297.2M
Current Shares
5.4M
Total Value Change
+$239.1M
Total Shares Change
+4M
Quarter-by-Quarter History
Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors